BRPI0512546A - método para diagnosticar lawsonia intracellularis - Google Patents

método para diagnosticar lawsonia intracellularis

Info

Publication number
BRPI0512546A
BRPI0512546A BRPI0512546-4A BRPI0512546A BRPI0512546A BR PI0512546 A BRPI0512546 A BR PI0512546A BR PI0512546 A BRPI0512546 A BR PI0512546A BR PI0512546 A BRPI0512546 A BR PI0512546A
Authority
BR
Brazil
Prior art keywords
lawsonia intracellularis
diagnosing
diagnosing lawsonia
relates
test kit
Prior art date
Application number
BRPI0512546-4A
Other languages
English (en)
Inventor
Malik Merza
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04014804A external-priority patent/EP1609870A1/en
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of BRPI0512546A publication Critical patent/BRPI0512546A/pt
Publication of BRPI0512546B1 publication Critical patent/BRPI0512546B1/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

MéTODO PARA DIAGNOSTICAR LAWSONIA INTRACELLULARIS. A presente invenção refere-se ao campo da saúde animal e em particular a Lawsonía intraceliularis. Em particular a invenção refere-se a um método para diagnosticar infecção por Lawsonia intracellularis e um kit de teste diagnóstico usando anticorpos específicos contra Lawsonia intracellularis. A invenção também refere-se à aplicação do método ou kit de teste para diagnosticar infecções por Lawsonia intracellularis.
BRPI0512546A 2004-06-24 2005-06-23 método para diagnosticar lawsonia intracellularis BRPI0512546B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04014804A EP1609870A1 (en) 2004-06-24 2004-06-24 Method of diagnosing lawsonia intracellularis
EP04027193 2004-11-16
PCT/EP2005/006781 WO2006012949A1 (en) 2004-06-24 2005-06-23 Method of diagnosing lawsonia intracellularis

Publications (2)

Publication Number Publication Date
BRPI0512546A true BRPI0512546A (pt) 2008-03-25
BRPI0512546B1 BRPI0512546B1 (pt) 2016-07-19

Family

ID=34971368

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512546A BRPI0512546B1 (pt) 2004-06-24 2005-06-23 método para diagnosticar lawsonia intracellularis

Country Status (21)

Country Link
US (12) US7303891B2 (pt)
EP (1) EP1761785B1 (pt)
JP (1) JP2008503737A (pt)
KR (2) KR101306610B1 (pt)
CN (1) CN1973205B (pt)
AR (1) AR049411A1 (pt)
AT (1) ATE479100T1 (pt)
AU (1) AU2005269043B2 (pt)
BR (1) BRPI0512546B1 (pt)
CA (1) CA2568821C (pt)
CY (1) CY1110948T1 (pt)
DE (1) DE602005023157D1 (pt)
DK (1) DK1761785T3 (pt)
MX (1) MXPA06015207A (pt)
MY (1) MY146476A (pt)
PL (1) PL1761785T3 (pt)
PT (1) PT1761785E (pt)
RU (1) RU2400758C2 (pt)
SI (1) SI1761785T1 (pt)
TW (1) TW200617174A (pt)
WO (1) WO2006012949A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
US8398970B2 (en) * 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
US10125388B2 (en) 2007-10-31 2018-11-13 Akonni Biosystems, Inc. Integrated sample processing system
ES2534556T3 (es) 2008-07-22 2015-04-24 Intervet International Bv Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
US8518658B1 (en) * 2009-04-27 2013-08-27 University Of South Florida ATP-bioluminescence immunoassay
CA3041540C (en) 2009-09-21 2021-08-24 Bio-Rad Laboratories, Inc. Magnetic lysis method and device
EP2523434A1 (en) 2011-05-11 2012-11-14 10n2 Technologies, Inc. A method for limiting the use of a mobile communications device dependent on the travelling speed
CN103698514B (zh) * 2013-12-17 2015-11-18 广西大学 检测猪胞内劳森氏菌抗体的elisa试剂盒

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130232A (en) * 1990-06-12 1992-07-14 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibody immunoassay kit for avian reticuloendotheliosis virus
JP3547022B2 (ja) * 1994-12-16 2004-07-28 富士写真フイルム株式会社 磁気記録媒体
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5714375A (en) 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
CA2236574A1 (en) 1995-11-30 1997-06-05 Daratech Pty. Ltd. Therapeutic and diagnostic compositions
EP0974660A1 (en) 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle disease virus infectious clones, vaccines and diagnostic assays
CN1260492A (zh) * 1999-11-09 2000-07-19 赵永同 肿瘤预后评估试剂盒及其制备工艺
WO2002026250A2 (en) 2000-09-29 2002-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Vaccines for proliferative ileitis
DE60144201D1 (de) * 2000-12-20 2011-04-21 Intervet Int Bv Lawsonia intracellularis Impfstoff
JP4079727B2 (ja) 2002-09-06 2008-04-23 セントラル硝子株式会社 光学活性１−（フルオロ、トリフルオロメチルまたはトリフルオロメトキシ置換フェニル）アルキルアミンｎ−モノアルキル誘導体とその製造方法
JP2006501846A (ja) 2002-10-04 2006-01-19 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ローソニア・イントラセルラリス由来の核酸およびポリペプチド配列ならびに使用方法
ATE470673T1 (de) 2004-01-22 2010-06-15 Intervet Int Bv Impfstoffe mit lawsoniaintrazellularis- untereinheit
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis

Also Published As

Publication number Publication date
RU2007102426A (ru) 2008-07-27
CN1973205A (zh) 2007-05-30
EP1761785A1 (en) 2007-03-14
US8007801B1 (en) 2011-08-30
MY146476A (en) 2012-08-15
KR20070026855A (ko) 2007-03-08
BRPI0512546B1 (pt) 2016-07-19
US8058062B1 (en) 2011-11-15
US20110201790A1 (en) 2011-08-18
KR101306610B1 (ko) 2013-09-11
US20110033870A1 (en) 2011-02-10
DK1761785T3 (da) 2010-11-08
US7799562B2 (en) 2010-09-21
US7993649B1 (en) 2011-08-09
ATE479100T1 (de) 2010-09-15
US20110201786A1 (en) 2011-08-18
US8114667B2 (en) 2012-02-14
US20110201789A1 (en) 2011-08-18
CY1110948T1 (el) 2015-06-10
TW200617174A (en) 2006-06-01
DE602005023157D1 (de) 2010-10-07
US8114666B2 (en) 2012-02-14
CA2568821A1 (en) 2006-02-09
SI1761785T1 (sl) 2010-12-31
JP2008503737A (ja) 2008-02-07
US8003107B1 (en) 2011-08-23
US20110275148A1 (en) 2011-11-10
PL1761785T3 (pl) 2011-02-28
CA2568821C (en) 2017-02-14
MXPA06015207A (es) 2007-03-26
US20110275149A1 (en) 2011-11-10
US7635590B2 (en) 2009-12-22
US7960174B2 (en) 2011-06-14
US20110275147A1 (en) 2011-11-10
KR20130012085A (ko) 2013-01-31
US20080102479A1 (en) 2008-05-01
US7303891B2 (en) 2007-12-04
US20110201788A1 (en) 2011-08-18
US20100112608A1 (en) 2010-05-06
US20070003991A1 (en) 2007-01-04
RU2400758C2 (ru) 2010-09-27
PT1761785E (pt) 2010-11-10
EP1761785B1 (en) 2010-08-25
AU2005269043A1 (en) 2006-02-09
AU2005269043B2 (en) 2011-10-27
US8021663B2 (en) 2011-09-20
US8007802B1 (en) 2011-08-30
WO2006012949A1 (en) 2006-02-09
CN1973205B (zh) 2012-07-18
AR049411A1 (es) 2006-07-26
KR101389302B1 (ko) 2014-04-25
US20110201787A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
BRPI0512546A (pt) método para diagnosticar lawsonia intracellularis
Samaha et al. Multicenter study of brucellosis in Egypt
BR112018016226A8 (pt) Anticorpo antilipoarabinomanana (anti-lam) monoclonal humano, kit para detectar pelo menos um epítopo de lam, método para diagnosticar uma infecção de tuberculose ativa em um indivíduo, método para tratar uma infecção de tuberculose em um indivíduo, anticorpo monoclonal humano anti-lam e método de pré-concentração de lam a partir de uma amostra biológica
WO2008021290A8 (en) Organ-specific proteins and methods of their use
NO20061169L (no) Prober for sykdommer hvor amyloid akkumulerer midler for a farge amyloidlegemidler for behandling og profylakse av sykdommer med akkumulert innhold og prober for diagnoser av nevrofibrilaere knuter og legemidler for a farge nevrofibrilaere knuter
BRPI0906665B8 (pt) sistema para detecção de um analito em um fluido corpóreo
UY31114A1 (es) Anticuerpos humanizados contra el globulómero ab(20-42) y sus usos
WO2007087261A3 (en) Rapid test apparatus
BRPI0515111A (pt) monitoramento de gligose salivar
BRPI1009276A2 (pt) painel, kit, dispositivo, método e meio legível por computador para teste diagnóstico rápido para uso na diagnose de malária e infecção bacteriana grave numa amostra de teste
BR0313194A (pt) Método para diagnose de esclerose múltipla
UY30797A1 (es) Un método mediante una prueba de aliento para la deteccion de microorganismos patogenos
Picasso-Risso et al. Diagnostic interaction between bovine tuberculosis (bTB) and Johne's disease in bTB highly prevalent dairy farms of Uruguay
UA88307C2 (en) Method for diagnostics of lawsonia intracellularis
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
DK2167676T3 (da) Kit til sekventiel måling af (1) den enzymatisk aktive fraktion og (2) den samlede mængde af et enzym
Vliegenthart-Jongbloed et al. Imported scrub typhus in The Netherlands
BR112022020143A2 (pt) Teste de diagnóstico de patógeno
Goletic et al. Serologic and molecular evidence for circulation of Crimean-Congo hemorrhagic fever virus in ticks and cattle in Bosnia and Herzegovina
Wahi et al. Assessment of levels of glycosylated hemoglobin in patients with periodontal pathologies: A comparative study
GB202006144D0 (en) Method of diagnosing a biological entity, and diagnostic device
Migchelsen et al. P3. 213 A tool for evaluating the impact of the national chlamydia screening programme in england: c. trachomatis antibody prevalence in young women in england (2007–2015)
Trinh et al. O03. 6 Syphilis testing practices in the americas: results of a regional survey of laboratories
Fingerhuth et al. P3. 212 Antibiotic resistance detection is essential for gonorrhoea point-of-care testing: a mathematical modelling study
BR112023001575A2 (pt) Método in vitro ou ex vivo para diagnóstico ou prognóstico de doença neurodegenerativa e uso de um kit diagnóstico para implementação do mesmo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/07/2016, OBSERVADAS AS CONDICOES LEGAIS.